BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30621767)

  • 1. Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians' current practices.
    Yuskiv N; Potter BK; Stockler S; Ueda K; Giezen A; Cheng B; Langley E; Ratko S; Austin V; Chapman M; Chakraborty P; Collet JP; Pender A;
    Orphanet J Rare Dis; 2019 Jan; 14(1):7. PubMed ID: 30621767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe.
    Lowe TB; DeLuca J; Arnold GL
    Orphanet J Rare Dis; 2020 Sep; 15(1):266. PubMed ID: 32977849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach.
    Singh RH; Cunningham AC; Mofidi S; Douglas TD; Frazier DM; Hook DG; Jeffers L; McCune H; Moseley KD; Ogata B; Pendyal S; Skrabal J; Splett PL; Stembridge A; Wessel A; Rohr F
    Mol Genet Metab; 2016 Jun; 118(2):72-83. PubMed ID: 27211276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
    Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
    Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria.
    Muntau AC; Adams DJ; Bélanger-Quintana A; Bushueva TV; Cerone R; Chien YH; Chiesa A; Coşkun T; de Las Heras J; Feillet F; Katz R; Lagler F; Piazzon F; Rohr F; van Spronsen FJ; Vargas P; Wilcox G; Bhattacharya K
    Mol Genet Metab; 2019 May; 127(1):1-11. PubMed ID: 31103398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylalanine hydroxylase deficiency treatment and management: A systematic evidence review of the American College of Medical Genetics and Genomics (ACMG).
    Adams AD; Fiesco-Roa MÓ; Wong L; Jenkins GP; Malinowski J; Demarest OM; Rothberg PG; Hobert JA;
    Genet Med; 2023 Sep; 25(9):100358. PubMed ID: 37470789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the use of sapropterin in phenylketonuria.
    Cunningham A; Bausell H; Brown M; Chapman M; DeFouw K; Ernst S; McClure J; McCune H; O'Steen D; Pender A; Skrabal J; Wessel A; Jurecki E; Shediac R; Prasad S; Gillis J; Cederbaum S
    Mol Genet Metab; 2012 Jul; 106(3):269-76. PubMed ID: 22575621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Women With Phenylalanine Hydroxylase Deficiency (Phenylketonuria): ACOG Committee Opinion Summary, Number 802.
    Obstet Gynecol; 2020 Apr; 135(4):987-988. PubMed ID: 32217972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Women With Phenylalanine Hydroxylase Deficiency (Phenylketonuria): ACOG Committee Opinion, Number 802.
    Obstet Gynecol; 2020 Apr; 135(4):e167-e170. PubMed ID: 32217978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of neonatal protein metabolism and nutrition on screening for phenylketonuria.
    Ponzone A; Spada M; Roasio L; Porta F; Mussa A; Ferraris S
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):561-9. PubMed ID: 18493213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized long-term outcomes in blood phenylalanine concentrations and dietary phenylalanine tolerance in 11 patients with primary phenylalanine hydroxylase (PAH) deficiency treated with Sapropterin-dihydrochloride.
    Stockler-Ipsiroglu S; Yuskiv N; Salvarinova R; Apatean D; Ho G; Cheng B; Giezen A; Lillquist Y; Ueda K
    Mol Genet Metab; 2015 Mar; 114(3):409-14. PubMed ID: 25497838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence.
    Enns GM; Koch R; Brumm V; Blakely E; Suter R; Jurecki E
    Mol Genet Metab; 2010; 101(2-3):99-109. PubMed ID: 20678948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to clinic recommendations among patients with phenylketonuria in the United States.
    Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL
    Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM).
    Thomas J; Levy H; Amato S; Vockley J; Zori R; Dimmock D; Harding CO; Bilder DA; Weng HH; Olbertz J; Merilainen M; Jiang J; Larimore K; Gupta S; Gu Z; Northrup H;
    Mol Genet Metab; 2018 May; 124(1):27-38. PubMed ID: 29653686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary management practices in phenylketonuria across European centres.
    Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
    Clin Nutr; 2009 Jun; 28(3):231-6. PubMed ID: 19362397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data.
    Rohr F; Burton B; Dee A; Harding CO; Lilienstein J; Lindstrom K; MacLeod E; Rose S; Singh R; van Calcar S; Whitehall K
    Mol Genet Metab; 2024 Mar; 141(3):108122. PubMed ID: 38184920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylketonuria (PKU): A problem solved?
    Brown CS; Lichter-Konecki U
    Mol Genet Metab Rep; 2016 Mar; 6():8-12. PubMed ID: 27014571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
    Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
    Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase.
    Rocha JC; Bausell H; Bélanger-Quintana A; Bernstein L; Gökmen-Özel H; Jung A; MacDonald A; Rohr F; van Dam E; Heddrich-Ellerbrok M
    Mol Genet Metab Rep; 2021 Sep; 28():100771. PubMed ID: 34094869
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.